SCHEMBL29935937

SCHEMBL29935937

Cc1cccc2c(C=O)cnn12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 1/20 0.41
DRD2 P14416 2/20 0.37
DRD4 P21917 2/20 0.37
DRD3 P35462 2/20 0.37
ALDH1A1 P00352 4/20 0.36
IMPDH2 P12268 1/20 0.36
TSHR P16473 1/20 0.35
TDP1 Q9NUW8 2/20 0.34
POLB P06746 1/20 0.34
APEX1 P27695 1/20 0.34
CTDSP1 Q9GZU7 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
SSTR4 P31391 3/20 0.34
TLR8 Q9NR97 1/20 0.33
LMNA P02545 2/20 0.32
MEN1 O00255 1/20 0.32
THRB P10828 1/20 0.32
BLM P54132 1/20 0.32
KMT2A Q03164 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31596040 0.79 DRD2 (0.37) DRD2DRD4DRD3ALDH1A1IMPDH2
SCHEMBL29935571 0.78 DRD2 (0.44) DRD2DRD4DRD3ALDH1A1IMPDH2
SCHEMBL31596205 0.76 DRD2 (0.34) DRD2DRD4DRD3ALDH1A1IMPDH2
SCHEMBL23109051 0.73 DRD2 (0.50) PIK3CADRD2DRD4DRD3ALDH1A1
SCHEMBL23089307 0.72 DRD2 (0.40) PIK3CADRD2DRD4DRD3ALDH1A1
SCHEMBL24729869 0.72 DRD2 (0.40) PIK3CADRD2DRD4DRD3SSTR4
SCHEMBL29935834 0.70 ALDH1A1 (0.39) ALDH1A1TSHRL3MBTL1TLR8LMNA
SCHEMBL30842018 0.69 DYRK1A (0.37) DRD2DRD4DRD3TLR8KDM4E
SCHEMBL23132317 0.69 DRD2 (0.38) PIK3CADRD2DRD4DRD3TSHR
SCHEMBL3076662 0.68 HPGD (0.49) ALDH1A1TSHRTDP1POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113164458-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-13 CN claimed
CN-113164459-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-03 CN claimed
US-12577243-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2026-03-17 US disclosed
CN-113164458-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-13 CN disclosed
CN-113164459-B Monoacylglycerol lipase modulators 詹森药业有限公司 2024-09-03 CN disclosed
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed
US-20220332713-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332713-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP PIK3CA 519/4885DRD2 955/4885DRD4 1861/4885
US-12577243-B2 Monoacylglycerol lipase modulators MGLL, LPL, FAAH PIK3CA 1797/4885DRD2 497/4885DRD4 1036/4885
US-20230145249-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP PIK3CA 519/4885DRD2 955/4885DRD4 1861/4885
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP PIK3CA 519/4885DRD2 955/4885DRD4 1861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.